Emanuela Taioli, MD, PhD
img_Emanuela Taioli
DIRECTOR, INSTITUTE FOR TRANSLATIONAL EPIDEMIOLOGY
PROFESSOR | Population Health Science and Policy
PROFESSOR | Thoracic Surgery
Research Topics
Biostatistics, Cancer, Epidemiology, Healthcare, Lung, Obesity, Personalized Medicine, Public Health, Thyroid, Translational Research
Cancer Epidemiology

My research interest and expertise is in the area of cancer epidemiology. I have published widely on environmental carcinogens, cancer and nutrition, and genetic susceptibility to cancer. I am internationally known for my       work in cancer prevention which includes the study of cancer risk factors in healthy populations, cancer predisposing factors, hormone metabolism and genetic susceptibility to environmental exposure; cancer survivorship   and the effect of lifestyles changes on the risk for cancer recurrence and the development of new secondary cancers; health disparity, access to care in minorities, and chronic diseases prevention in the underserved. I am the Director of the Center for the Study of Thoracic Diseases Outcomes and in that capacity I work closely with surgeons, radiologists and immunologists on lung cancer early detection and treatment studies.

MD, University of Milan

PhD, Columbia University School of Arts and Science

Publications

Selected Publications

Longitudinal Assessment of Association Between Tobacco Use and Tobacco Dependence Among Adults: Latent Class Analysis of the Population Assessment of Tobacco and Health Study Waves 1-4. Lihua Li, Chen Yang, Serena Zhan, Karen M. Wilson, Emanuela Taioli, Madhu Mazumdar, Bian Liu. Nicotine and Tobacco Research

A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts. Laura Bravo, Joana FF Simões, Victor R. Cardoso, Adewale Adisa, Maria L. Aguilera, Alexis Arnaud, Bruce Biccard, Jose Calvache, Saisakul Chernbumroong, Muhammed Elhadi, Dhruv Ghosh, Rohan Gujjuri, Ewen Harrison, Michael WS Ho, Veerappan Kasivisvanathan, Omar Kouli, Hans Lederhuber, Elizabeth Li, Markus W. Löffler, Arda Isik, Hani Marcus, Janet Martin, Kenneth A. McLean, Ana Minaya-Bravo, María Marta Modolo, Dmitri Nepogodiev, Gianluca Pellino, Maria Picciochi, Peter Pockney, Gabriëlle van Ramshorst, Aya Riad, Raza Sayyed, Malin Sund, Georgios Gkoutos, Aneel A. Bhangu, James C. Glasbey, V. Cardoso, J. Glasbey, J. F.F. Simoes, B. Kadir, O. Omar, E. Revell, M. Bahrami-Hessari, Waheed Ul Rahman Ahmed, Leah Argus, Alasdair Ball, Aneel Bhangu, E. Taioli, E. Gleeson, U. Sarpel. The Lancet Digital Health

Outcomes in Incidentally Versus Screening Detected Stage I Lung Cancer Surgery Patients. Shubham Gulati, Tara Ivic-Pavlicic, Jonathan Joasil, Raja Flores, Emanuela Taioli. Journal of Thoracic Oncology

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Taioli during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • American Cancer Society
  • Forrest Weldon law group
  • Milliman

Founder/Co-Founder/Partner

  • Science Policy Institute

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.